Welcome to the New Mexico Chapter of the American College of Cardiology
ACC Live Courses For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings |
Please join your cardiology colleagues at the ACC Rockies Chapter Meeting in Park City, Utah for updates on ACC affairs, the potential new CV Board, and clinical topics such as Genetic and Sports EP, plus a discussion on the growing role of obesity medications in heart failure, and the first-ever Cardiology State-of-the-State report. There will be many opportunities for networking, as well!.
For more information and to register, please visit: 
Latest in Cardiology from ACC.org
- FOURIER Analysis Looks at Evolocumab and Risk of MACE Stratified by ObesityEvolocumab can help attenuate the elevated risk of major adverse cardiovascular events (MACE) that individuals with obesity and atherosclerotic cardiovascular disease (ASCVD) face, according to a prespecified analysis from the FOURIER trial published Dec. 10 in JACC.
- PDA Trial: Preterm Infant Patent Ductus Arteriosus: Expectant Management vs. Active TreatmentExpectant management for patent ductus arteriosus (PDA) in preterm infants did not lower risk of death or lung disease compared with active treatment. However, more infants survived in the expectant management group, according to results from the PDA trial published Dec. 9 in JAMA.
- Mechanisms Causing AV Block During TAVR Differ From Delayed Heart BlockAmong patients undergoing TAVR, the characteristics and mechanisms causing atrioventricular (AV) conduction block during the procedure differed from those after the procedure, according to a study published Dec. 10 in JAMA Cardiology.
- Is Long COVID Associated With Autonomic Dysfunction?Patients with long COVID may demonstrate persistent autonomic dysfunction that is similar to patients with pure autonomic failure when adjusted for age and sex, according to a study published Dec. 10 in JACC.
- Is a Multimodal AI Model Superior to LVEF in Predicting SCD in Patients With CS?When predicting sudden cardiac death (SCD) risk in patients with cardiac sarcoidosis (CS), a multimodal artificial intelligence (AI) for ventricular risk stratification in CS (MAARS-CS) may offer superior predictive accuracy and consistency vs. LVEF, according to a retrospective cohort study published Dec. 5 in JACC: Clinical Electrophysiology.